Trump Administration Deals Cut U.S. Global Health Aid 59% by 2030 as Congress Resists
Updated
Updated · The Washington Post · Aug 31
Trump Administration Deals Cut U.S. Global Health Aid 59% by 2030 as Congress Resists
1 articles · Updated · The Washington Post · Aug 31
Summary
A new nonprofit analysis of bilateral agreements with 18 countries found the Trump administration is seeking to shrink U.S. global health funding to developing nations by 59% from 2024 levels by 2030.
The projected cuts stem from post-inauguration deals pursued after Washington paused foreign aid and dismantled USAID, with recipient countries required in most cases to raise their own health spending as U.S. support falls.
State Department figures put the agreements at $14.5 billion in new U.S. assistance and $10.1 billion in recipient co-investment, while the department says it still intends to spend congressionally appropriated health funds through other channels.
The analysis says the deepest reductions hit poorer African countries reliant on HIV funding, including Rwanda dropping to 3% of prior U.S. support and Burundi to 22%, raising doubts they can fill the gap without program breakdowns.
Congress has largely kept global health funding intact despite Trump's push for self-reliance, and advocates say billions in separately approved PEPFAR money remain underspent, risking disruptions before funds are deployed.
As global health funding shrinks, will high-tech delivery drones be enough to prevent a devastating resurgence of infectious diseases?
Could the aggressive push for health self-reliance inadvertently trigger a catastrophic collapse of global outbreak surveillance by 2030?
What hidden privacy risks lie within the new bilateral agreements demanding exclusive access to developing nations' biological data?
U.S. Foreign Aid Slashed by 57% (2025–2026): Humanitarian Crisis, Legal Battles, and China’s Rise
Overview
In 2025, the U.S. government rapidly froze and canceled most foreign aid, dissolving USAID and shifting its functions to the State Department. This led to a sharp drop in global health spending, especially for HIV programs, and triggered severe humanitarian crises in countries like Sudan and the Democratic Republic of the Congo, where vital health and food services collapsed. The U.S. also withdrew from the WHO, creating a global leadership vacuum that China quickly moved to fill with its Health Silk Road initiative. These changes weakened disease surveillance, delayed outbreak detection, and left both global and U.S. health security at risk.